| Cat. No. |
Product Name |
Information |
| PC-20792 |
A-420983
Lck inhibitor
|
A-420983 is a potent, orally active inhibitor of Lck kinase with IC50 of 37 nM, inhibits whole blood IL-2 production with IC50 of 7 nM. |
| PC-49800 |
Toosendanin
Hck/Lyn inhibitor
|
Toosendanin is a small-molecule compound that blocks macrophage-mediated immunosuppression and activates T cells by inhibiting Hck and Lyn kinases, reprograms macrophages to enforce antitumor immunity in glioblastoma (GBM). |
| PC-42434 |
TG 100801 hydrochloride
|
The prodrug of TG 100572, a potent, dual receptor tyrosine kinase/Src kinase inhibitor with IC50 of 2-16 nM for VEGFR, FGFR and PDGFR, 0.1-5 nM for Src family. |
| PC-42303 |
Src Inhibitor 1
|
A potent, selective dual site inhibitor of Src tyrosine kinase with Ki of 15 nM. |
| PC-42690 |
Lck inhibitor 2
|
A potent tyrosine kinases inhibitor with IC50 of 13/9/3/26/2 nM for Lck/Btk/Lyn/Syk/Txk.. |
| PC-42057 |
WEHI-345 analog
|
A potent Src inhibitor extracted from patent WO/2012003544A1.. |
| PC-43793 |
1-Naphthyl PP1 hydrochloride
|
A potent Src family kinases with IC50 of 1.0/0.6/0.6 uM for v-Sr/c-Fyn/c-Abl. |
| PC-42539 |
KX2-391 mesylate
|
A highly selective, non-ATP competitive substrate-pocket-directed Src/pretubulin inhibitor. |
| PC-42538 |
KX2-391 dihydrochloride
|
A highly selective, non-ATP competitive substrate-pocket-directed Src/pretubulin inhibitor. |
